Eagle Genomics

The enterprise R&D knowledge discovery platform


Eagle Genomics’ AI augmented knowledge discovery platform is revolutionising how scientists conduct life sciences research and is bridging the gap between data and new insights in a rapid, systematic and traceable way. It puts data science at the fingertips of biologists to drastically reduce time and cost of research, Eagle is enabling customers in the fields of food, agriculture, personal care and more to achieve radical productivity improvements and true data-driven discovery.


Anthony Finbow

CEO, Eagle Genomics

"I have known the partners at ETF for many years and have been impressed with their work and with the portfolio that they have built. Through my career as an entrepreneur I have been very keen to work with them and as the leading sustainability orientated investor I am delighted to now have ETF as a shareholder. Eagle Genomics is addressing a grand challenge with sustainability at its root and I know that the unique expertise and engagement that ETF will bring will be a tremendous asset as we scale the business."

Related News

Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend
27 Oct 2020
Read More
Cargill and Eagle Genomics agree to multi-year platform engagement to accelerate microbiome discovery
20 May 2020
Read More
The most stark lesson that the coronavirus “infodemic” has taught us about data collaboration – Eagle Genomic’s first series of blogs on COVID-19
27 Apr 2020
Read More
RB brings digital R&D advances to popular consumer products through collaboration with Eagle Genomics
20 Mar 2020
Read More
Former French Secretary of State joins Eagle Genomics’ Board of Directors
25 Nov 2019
Read More
Eagle Genomics Startup story features on the Microsoft Startup homepage
16 May 2019
Read More
ETF Partners invests in Eagle Genomics
31 Jan 2019
Read More